In the journey to support individuals on the autism spectrum, it’s essential to recognize the frequent overlap with ADHD (Attention Deficit Hyperactivity Disorder). Many families and caregivers of autistic children and adults also navigate the challenges of ADHD—struggling with focus, impulsivity, and restlessness that can complicate learning and daily life.
That’s why it’s important to stay informed about evolving treatment options. One such option is JORNAY PM®, an extended-release form of methylphenidate HCl. This medication is designed to be taken at night, with effects that begin the next morning—offering a potentially smoother start to the day for patients who struggle with early-morning focus and behavior regulation.
Upcoming National Webcast – Learn More:
Collegium Pharmaceutical invites healthcare professionals and caregivers to a national virtual webcast on Tuesday, May 20, 2025 to discuss the JORNAY PM approach in ADHD treatment. Two sessions are available:
-
Session 1: 7:00 PM ET / 6:00 PM CT / 4:00 PM PT
-
Session 2: 9:00 PM ET / 8:00 PM CT / 6:00 PM PT
Scan the QR codes in the flyer to register, or visit JORNAYPM-pro.com/PI for prescribing information.
Why This Matters for the Autism Community:
While JORNAY PM is approved for ADHD in children 6 and older, its unique delivery system may benefit some autistic individuals who also experience ADHD symptoms. However, it’s crucial to consider this option carefully and consult with healthcare providers who understand both autism and ADHD.
Important Safety Information:
JORNAY PM carries a Boxed Warning for potential abuse, misuse, and addiction—a serious concern that must be monitored. Families and doctors should work together to assess risk and ensure responsible use.
Presented by Expert Faculty:
Dr. Ann Childress, MD—a psychiatrist and president of the Center for Psychiatry and Behavioral Medicine, will guide the session, helping attendees understand unmet ADHD needs and explore the clinical data behind JORNAY PM.
A Final Thought for Our Autism Awareness Community:
Every individual on the spectrum is unique. Medications like JORNAY PM are not a one-size-fits-all solution, but learning about them empowers us to make informed, personalized decisions. Stay aware. Stay educated. And always advocate with compassion.
#AutismAwareness #ADHDTreatment #JORNAYPM #Neurodiversity #MentalHealthMatters #AutismAndADHD #ParentAdvocacy #InformedChoices #SupportAutisticVoices
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.